Search Results - "Siripoon, Tanaya"
-
1
High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients
Published in The American journal of tropical medicine and hygiene (03-05-2021)“…Exuberant inflammation manifesting as a "cytokine storm" has been suggested as a central feature in the pathogenesis of severe coronavirus disease 2019…”
Get full text
Journal Article -
2
'Strongyloides stercoralis': A neglected but fatal parasite
Published in Tropical medicine and infectious disease (17-10-2022)“…Strongyloidiasis is a disease caused by 'Strongyloides stercoralis' and remains a neglected tropical infection despite significant public health concerns…”
Get full text
Journal Article -
3
Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
Published in BMC infectious diseases (07-10-2024)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), led to a global pandemic from 2020. In…”
Get full text
Journal Article -
4
Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand
Published in mSphere (21-02-2023)“…The humoral immune response plays a key role in protecting the population from SARS-CoV-2 transmission. Patients who recovered from COVID-19 as well as fully…”
Get full text
Journal Article -
5
Temporal trend of COVID-19 vaccine acceptance and factors influencing international travellers
Published in Tropical medicine and infectious disease (01-09-2022)“…The COVID-19 pandemic has seen disrupted international travel due to travel restrictions and public health measures aimed at containing the spread of the…”
Get full text
Journal Article -
6
Clinical and immunological characteristics for BK polyomavirus‐associated nephropathy after kidney transplantation
Published in Immunity, Inflammation and Disease (01-08-2023)“…Introduction BK polyomavirus (BKPyV)‐associated nephropathy (BKPyVAN) can cause a significant risk of allograft impairment after kidney transplantation (KT)…”
Get full text
Journal Article -
7
Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand
Published in The American journal of tropical medicine and hygiene (14-11-2022)“…Chikungunya is a mosquito-borne disease mainly characterized by fever with polyarthralgia. Currently, liver complications of chikungunya remain rarely…”
Get full text
Journal Article -
8
Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Published in Infectious diseases and therapy (01-02-2022)“…Introduction Many immunomodulators have been studied in clinical trials for the treatment of coronavirus disease 2019 (COVID-19). However, data identifying the…”
Get full text
Journal Article -
9
Evidence of transmission of influenza A and influenza B co-infection in healthcare workers
Published in Journal of infection in developing countries (28-07-2022)“…Introduction: Co-infection of influenza A and B has been reported, especially in outbreak situations, but epidemiological and clinical information is limited…”
Get full text
Journal Article -
10
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial
Published in The Lancet infectious diseases (01-01-2024)“…Molnupiravir and ritonavir-boosted nirmatrelvir are the two leading oral COVID-19 antiviral treatments, but their antiviral activities in patients have not…”
Get full text
Journal Article -
11
-
12
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)
Published in The Journal of infectious diseases (15-11-2023)“…Abstract Background Uncertainty over the therapeutic benefit of parenteral remdesivir in coronavirus disease 2019 (COVID-19) has resulted in varying treatment…”
Get full text
Journal Article -
13
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Published in The Lancet infectious diseases (01-09-2024)“…Effective antiviral drugs prevent hospitalisation and death from COVID-19. Antiviral efficacy can be efficiently assessed in vivo by measuring rates of…”
Get full text
Journal Article -
14
1382. A Prospective Epidemiological Study BK Polyomavirus DNAuria and DNAemia within the First Year after Kidney Transplantation
Published in Open forum infectious diseases (04-12-2021)Get full text
Journal Article -
15
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Published in BMC infectious diseases (15-01-2024)“…In early symptomatic COVID-19 treatment, high dose oral favipiravir did not accelerate viral clearance. Favipiravir, an anti-influenza drug, has in vitro…”
Get full text
Journal Article -
16
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Published in eLife (21-02-2023)“…There is no generally accepted methodology for in vivo assessment of antiviral activity in SARS-CoV-2 infections. Ivermectin has been recommended widely as a…”
Get full text
Journal Article -
17
Clinical antiviral efficacy of remdesivir in COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV)
Published in The Journal of infectious diseases (20-07-2023)“…Uncertainty over the therapeutic benefit provided by parenteral remdesivir in COVID-19 has resulted in varying treatment guidelines. In a multicenter open…”
Get full text
Journal Article